论文部分内容阅读
目的 探讨阿立哌唑口崩片与舒必利片对女性精神分裂症患者疗效及生活质量的影响.方法 将80例女性精神分裂症患者采用随机数字表法分为两组,各40例,实验组予以阿立哌唑口崩片治疗,对照组予以舒必利片治疗,观察8周.于治疗前及治疗8周末分别采用阳性与阴性症状量表评定两组患者的临床疗效,生活质量综合评定问卷评定生活质量,于治疗第2周、4周、8周末采用副反应量表评定不良反应.结果 治疗8周末两组阳性与阴性症状量表总分及各因子分均较治疗前显著下降(P0.05);实验组总有效率为92.5%,对照组为90.0%,两组比较差异无显著性(P>0.05).实验组副反应量表评分显著低于对照组(P0.05).The TESS score was significantly lower in experimental than in control group (P<0.05 or 0.01).At the end of the 8th week the GQOLI-74 scores of both groups heightened more significantly compare with pretreatment (P<0.01) and so did that in experimental than in control group (P< 0.01).Conclusion Aripiprazole ODT and sulpiride tablet have an equivalent effect in the treatment of female schizophrenics,but the former has mild adverse reactions and better compliance and deserves clinical generalization and application.